Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page
- Check2 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a software update; the study content and details remain unchanged.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page displays a new Revision: v3.5.4, replacing the previous revision tag. This indicates a small, behind-the-scenes update to the page version rather than a change to the study details.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s displayed revision/version indicator was updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check74 days agoChange DetectedResults have been posted for the study, with corresponding QC dates noted. A PDF of the Study Protocol and Statistical Analysis Plan has been added to Study Documents.SummaryDifference1%

- Check81 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; the page now reflects the newer revision label.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.